--- title: "InMode (INMD) stock listing, news and investor profile" url: "https://aibio.space/companies/inmode/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "InMode Ltd. (NASDAQ: INMD), United States. Listing facts, related biotech companies and news on aibio.space." --- INMD InMode Ltd. NASDAQ · United States # InMode (INMD) news InMode Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker INMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest InMode news We have not published a story on InMode yet. When there is news, it will appear here. ## InMode at a glance - **Ticker**: INMD - **Listing**: NASDAQ - **Country**: United States - **Cash, Dec 31, 2025**: $386.2 million ### Related companies - [Autonomix Medical](https://aibio.space/companies/autonomix-medical/) NASDAQ: AMIX - [UFP TECHNOLOGIES INC](https://aibio.space/companies/ufp-technologies/) NASDAQ: UFPT - [INSULET CORP](https://aibio.space/companies/insulet/) NASDAQ: PODD - [Zoetis](https://aibio.space/companies/zoetis/) NYSE: ZTS - [Bluejay Diagnostics](https://aibio.space/companies/bluejay-diagnostics/) NASDAQ: BJDX - [NEOGENOMICS INC](https://aibio.space/companies/neogenomics/) NASDAQ: NEO - [Devonian Health Group](https://aibio.space/companies/devonian-health-dvhgf/) OTC: DVHGF - [Virax Biolabs Group](https://aibio.space/companies/virax-biolabs/) NASDAQ: VRAX ### Also on NASDAQ - [Adlai Nortye Group](https://aibio.space/companies/adlai-nortye/) ANL - [Tempus AI](https://aibio.space/companies/tempus-ai/) TEM - [Aligos Therapeutics](https://aibio.space/companies/aligos-therapeutics/) ALGS - [SCYNEXIS](https://aibio.space/companies/scynexis/) SCYX - [CVRx](https://aibio.space/companies/cvrx/) CVRX - [Aurinia Pharmaceuticals](https://aibio.space/companies/aurinia-pharmaceuticals/) AUPH ## InMode annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$370.5 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | [$394.8 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | | Research and development | [$13.3 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | [$13.1 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | | Cash from operations | [$85.3 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | [$132.7 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | | Cash and equivalents | [$302.5 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | [$155.3 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | | Short-term investments | [$83.6 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | [$267.7 million](https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $302.5 million, plus short-term investments of $83.6 million, $386.2 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about InMode What is the ticker symbol of InMode? InMode Ltd. trades under the ticker INMD on NASDAQ. Where is InMode listed? InMode Ltd. is listed on NASDAQ. Which country or territory is InMode listed under? Our directory records InMode Ltd. under United States. Does aibio.space cover InMode? aibio.space lists InMode Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. What was InMode's revenue last year? $370.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. How much does InMode spend on research and development? $13.3 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does InMode have? $386.2 million in cash and short-term investments at Dec 31, 2025, per its 20-F. ## Investor discussion: InMode Members talk about InMode (INMD). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at InMode, newest first. Each line links the filing it comes from. 1. 2026-06-25 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1742692/000117891326003341/zk2635614.htm) 2. 2026-05-06 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1742692/000117891326002402/exhibit_99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:INMD on TradingView](https://www.tradingview.com/symbols/NASDAQ-INMD/). ## Listing details InMode Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker INMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: InMode Ltd. - **Ticker**: INMD - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/inmode/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "InMode (INMD) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/inmode/